Blenrep 00173-0913
Generic: Belantamab Mafodotin
Product NDC
00173-0913- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Injection, Powder, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 23, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761440
Need to source Blenrep? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Belantamab Mafodotin | 50 mg/mL |
Packaging Options(1)
1 VIAL in 1 CARTON (0173-0913-01) / 1.4 mL in 1 VIAL